Epicriptine
From Wikipedia, the free encyclopedia
Main article: Dihydroergocryptine
![]() |
|
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration |
Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
|
|
Synonyms | beta-Dihydroergocryptine |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.039.157 |
Chemical and physical data | |
Formula | C32H43N5O5 |
Molar mass | 577.715 g/mol |
3D model (Jmol) | |
|
|
|
Epicriptine or beta-dihydroergocryptine is a dopamine agonist of the ergoline class. It constitutes one third of the mixture known as dihydroergocryptine, the other two thirds consisting of alpha-dihydroergocryptine. The alpha differs from the beta form only in the position of a single methyl group, which is a consequence of the biosynthesis in which the proteinogenic amino acid isoleucine is replaced by leucine.[1]
References[edit]
- ^ Steinhilber, D; Schubert-Zsilavecz, M; Roth, HJ (2005). Medizinische Chemie (in German). Stuttgart: Deutscher Apotheker Verlag. p. 142. ISBN 3-7692-3483-9.
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |